Advertisement
Screener

XERIS BIOPHARMA HOLDINGS, INC. (XERS) ROE

XERIS BIOPHARMA HOLDINGS, INC. (XERS) ROE

  • 2026-06-30: ROE 176.34%.
  • 2026-03-31: ROE 92.29%.
  • 2025-12-31: ROE 4.05%.
  • 2025-09-30: ROE 1816.49%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30176.34%
2026-03-3192.29%
2025-12-314.05%
2025-09-301816.49%
2025-06-30165.76%
2025-03-31128.32%
2024-12-31185.16%
2024-09-30222.83%
2024-06-30308.85%
2024-03-31701.69%
2023-12-31917.94%
2023-09-30-1598.84%
2023-06-30-523.69%
2023-03-31-258.85%
2022-12-31-209.49%
2022-09-30-240.77%
2022-06-30-184.87%
2022-03-31-143.10%
2021-12-31-128.87%
2021-09-303811.13%
2021-06-30-421.27%
2021-03-31-181.06%
2020-12-31-269.96%

Annual ROE

DateROE
2025-12-314.05%
2024-12-31185.16%
2023-12-31917.94%
2022-12-31-209.49%
2021-12-31-128.87%
2020-12-31-269.96%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
Xencor Inc (XNCR)United States$1.776B-7.33
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Septerna, Inc. (SEPN)United States$1.783B-63.01